Deccan Health Care Intrinsic Value
Deccan Health Care (DECCAN) median intrinsic value is ₹9.60 from 7 valuation models (range ₹4–₹31), vs current price ₹12.46 — -23.0% downside (Trading Above Calculated Value), margin of safety -29.8%. For current market price and key ratios, visit Deccan Health Care share price today.
DECCAN Valuation Methods Summary — DCF, Graham Number & P/E
Deccan Health Care intrinsic value across 7 models vs current price ₹12.46 — upside/downside and value range per method. Analyse DECCAN promoter holding to track promoter, FII and institutional holdings.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹6.72 | ₹5.38 - ₹8.06 | -46.1% | EPS: ₹0.56, Sector P/E: 12x |
| Book Value Method | asset | ₹31.15 | ₹28.04 - ₹34.27 | +150.0% | Book Value/Share: ₹44.00, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹24.92 | ₹22.43 - ₹27.41 | +100.0% | Revenue/Share: ₹33.60, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹9.60 | ₹8.64 - ₹10.56 | -23.0% | EBITDA: ₹4.00Cr, EV/EBITDA: 6x |
| PEG Ratio Method | growth | ₹3.74 | ₹3.37 - ₹4.11 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹4.61 | ₹4.15 - ₹5.07 | -63.0% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| Graham Defensive Method | conservative | ₹23.55 | ₹21.20 - ₹25.91 | +89.0% | EPS: ₹0.56, BVPS: ₹44.00 |
DECCAN Intrinsic Value vs Market Price — All Valuation Models
Deccan Health Care fair value range ₹4–₹31 vs current market price ₹12.46 across 7 valuation models. Read DECCAN dividend track record for the complete payout history and dividend yield track record.
DECCAN Intrinsic Value Analysis — Undervalued or Overvalued?
Deccan Health Care median intrinsic value ₹9.60, current price ₹12.46 — Trading Above Calculated Value by 23.0%, margin of safety -29.8%.
What is the intrinsic value of DECCAN?
Based on our comprehensive analysis using 7 different valuation methods, the estimated intrinsic value of Deccan Health Care (DECCAN) is ₹9.60 (median value). With the current market price of ₹12.46, this represents a -23.0% variance from our estimated fair value.
The valuation range spans from ₹3.74 to ₹31.15, indicating ₹3.74 - ₹31.15.
Is DECCAN undervalued or overvalued?
Based on our multi-method analysis, Deccan Health Care (DECCAN) appears to be trading above calculated value by approximately 23.0%.
DECCAN Financial Health — Key Ratios vs Industry Benchmarks
Deccan Health Care financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 26.00 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Operating Margin | 4.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.56x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
DECCAN Cash Flow Quality — Operating & Free Cash Flow
Deccan Health Care operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹-6 Cr | ₹-6 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹-13 Cr | ₹-13 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹-7 Cr | ₹-7 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹-1 Cr | ₹-1 Cr | Negative Cash Flow | 3/10 |
| March 2021 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |